Table 3

Montreal classification

Patients escalated to anti-TNFα therapyPatients successfully treated LDTA for 1 year
AgeM/FMontreal classificationAgeM/FMontreal classification
59MA3L2B166MA3L2B1
70FA3L2B155FA3L3B1
33FA2L3B139FA2L2B1
23FA2L3B348MA2L2B1
27FA2L3B1p44FA2L3B2
34FA1L2B128FA2L3B1p
36MA2L1B365FA3L1B2
66FA3L3B143MA2L1B3
85MA2L3B349MA3L2B1
35FA2L3B360MA3L1B1
60MA3L2B135FA1L3B1
28FA2L1B272MA3L2B1
66MA3L3B1
67MA3L2B1
  • Sex, p=0.267 (Fisher's exact).

  • Montreal classification: A (p=0.609), L (p=0.879), B (p=0.609) (Fisher’s exact).

  • Age, p=0.359 (Student's t test).

  • LDTA, low dose thiopurine and allopurinol.